Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.
Doximity Inc (DOCS) provides a HIPAA-secure digital platform connecting U.S. healthcare professionals through secure collaboration tools and medical networking features. This news hub offers investors and medical practitioners timely updates about platform developments, regulatory compliance milestones, and strategic partnerships.
Access comprehensive coverage of DOCS' operational updates including product innovations, financial results, and industry partnerships. All content is verified through primary sources to ensure accuracy for investment research and professional decision-making.
Key focus areas include updates on telehealth integrations, physician network expansion, and security protocol enhancements. Users benefit from centralized access to DOCS' regulatory filings, leadership announcements, and technology roadmap developments.
Bookmark this page for streamlined monitoring of Doximity's progress in advancing healthcare collaboration through its cloud-based platform. Check regularly for objective reporting on developments impacting both clinical workflows and long-term corporate strategy.
Doximity, Inc. (NYSE: DOCS) reported Q2 2023 total revenues of $102.2 million, a 29% year-over-year increase. Operating cash flow rose to $39.5 million (+106%), with free cash flow reaching $37.7 million (+109%). Net income fell to $26.3 million (margin of 26%) compared to the previous year, while non-GAAP net income was $36.2 million (35% margin). Doximity projects Q3 2023 revenue between $110.7 million and $111.7 million, affirming full-year revenue guidance of $424.0 million to $432.0 million. A $70 million stock repurchase program was also authorized.
Doximity, Inc. (NYSE:DOCS) announced it will report its financial results for the second quarter ending September 30, 2022, after market close on November 10, 2022. A conference call and webcast will be held at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity is a leading digital platform for U.S. medical professionals, boasting over 80% membership among U.S. physicians across all specialties, providing tools for collaboration, career management, and virtual patient visits.
Salvo Health has launched a virtual health clinic aimed at addressing chronic gut conditions for over 60 million Americans. The company recently secured $10.5 million in seed funding led by Threshold Ventures, along with Torch Capital and Felicis. Salvo Health offers a comprehensive care model, Whole Self Science, that integrates various health disciplines to provide personalized treatment plans. Their approach includes unlimited access to a dedicated care team, emphasizing root cause treatment over conventional methods. The company plans to expand its services across the U.S.
Doximity (NYSE: DOCS) recently appointed Phoebe L. Yang to its Board of Directors. Ms. Yang brings extensive health system and cloud expertise, having held key roles at Amazon Web Services and CommonSpirit Health. She was recognized as one of Modern Healthcare's Top 100 Most Influential People in Healthcare. Doximity CEO Jeff Tangney emphasized her dual expertise in healthcare and technology as pivotal for the company's growth and innovation in clinical tools. Yang expressed enthusiasm about contributing to Doximity's mission of enhancing physician productivity.
Doximity reported Q1 fiscal 2023 revenues of $90.6 million, a 25% increase year-over-year, alongside an operating cash flow of $44.8 million, up 35%. The net income of $22.4 million marked a decrease from the previous year's $26.3 million, leading to a margin drop from 36% to 25%. The company maintains a positive outlook, projecting Q2 revenue between $99.5 million and $100.5 million and adjusting full-year revenue guidance to between $424.0 million and $432.0 million.
Doximity, Inc. (NYSE: DOCS) will report its first-quarter financial results for the period ending June 30, 2022, after market close on August 4, 2022. A conference call to discuss these results will take place at 2:00 p.m. PT (5:00 p.m. ET). Doximity, founded in 2010, is the leading digital platform for U.S. medical professionals, encompassing over 80% of physicians across various specialties. The platform offers tools for collaboration, medical news updates, career management, and virtual patient visits, aiming to enhance productivity in healthcare.
Doximity, Inc. (NYSE: DOCS), a leading digital platform for U.S. medical professionals, announced its participation in two key investor conferences. The first is William Blair's 42nd Annual Growth Stock Conference on June 7, 2022, where Dr. Nate Gross will present at 5:40 pm ET. The second is the Goldman Sachs 43rd Annual Global Healthcare Conference on June 16, 2022, featuring CFO Anna Bryson at 11:40 am ET. Live webcasts will be available on Doximity's investor relations website.
Doximity reported Q4 revenue of $93.7 million, a 40% increase year-over-year, with a net income margin of 39%.
For fiscal year 2022, total revenue reached $343.5 million, up 66% year-over-year, with a net income margin of 45%.
The company projects Q1 revenue between $88.6 million and $89.6 million and updates fiscal 2023 guidance to $454.0 million to $458.0 million.
Doximity also announced a $70 million stock repurchase program to buy back shares over the next year.
Doximity, Inc. (NYSE:DOCS) is set to report its financial results for the fourth quarter ended March 31, 2022, after market close on May 17, 2022. A conference call and webcast will take place at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity stands as the leading digital platform for U.S. medical professionals, with over 80% of U.S. physicians in its network. Its mission is to enhance physician productivity to enable better patient care.
FAQ
What is the current stock price of Doximity (DOCS)?
What is the market cap of Doximity (DOCS)?
